(Q39721643)

14 September 2017

Antisense HIF-1alpha prevents acquired tumor resistance to angiostatin gene therapy (English)

1 reference

14 September 2017

0 references

X Sun

1

1 reference

14 September 2017

M Vale

2

1 reference

14 September 2017

X Jiang

3

1 reference

14 September 2017

R Gupta

4

1 reference

14 September 2017

G W Krissansen

5

1 reference

14 September 2017

26 March 2010

1 reference

14 September 2017

1 reference

14 September 2017

17

1 reference

14 September 2017

8

1 reference

14 September 2017

532-540

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2010.7

14 September 2017

0 references

cites work

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Antiangiogenic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

High level of stabilized angiostatin mediated by adenovirus delivery does not impair the growth of human neuroblastoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Regulation of gene expression by the hypoxia-inducible factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

HIF-1-regulated glucose metabolism: a key to apoptosis resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Gene transfer of antisense hypoxia inducible factor-1 alpha enhances the therapeutic efficacy of cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Antisense hypoxia-inducible factor-1alpha augments transcatheter arterial embolization in the treatment of hepatocellular carcinomas in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Nuclear expression of hypoxia-inducible factor-1alpha in clear cell renal cell carcinoma is involved in tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Hypoxia inducible factor-1 independent pathways in tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Vascular disrupting agents in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

Transplacental carcinogenesis by stilbestrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

inferred from DOI database lookup

7 January 2021

based on heuristic

Angiogenesis inhibitors suffer new setback

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

inferred from DOI database lookup

7 January 2021

based on heuristic

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2010.7

1 reference

14 September 2017

1 reference